← Open Payments lookup

JORGE MANCILLA: Open Payments

NPI 1013665926 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,588 in 116 payments from 10 companies in 2025. Trend: 2023 $2,375 · 2024 $2,211 · 2025 $2,588

Food & beverage: $2,365Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.20$567
E.R. Squibb & Sons, L.L.C.11$312
Neurocrine BioSciences, Inc.16$311
Janssen Pharmaceuticals, Inc5$289
Otsuka America Pharmaceutical, Inc.19$262
Alkermes, Inc.10$199
Lundbeck LLC8$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$193
ABBVIE INC.13$160
Axsome Therapeutics, Inc.5$100

Products named: REXULTI, COBENFY, INGREZZA, CAPLYTA, AUSTEDO XR, VRAYLAR, UZEDY, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.